日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

出版商更正:突变型 KRAS 疫苗联合双重免疫检查点阻断治疗切除胰腺癌:一项 I 期试验

Huff, Amanda L; Haldar, S Daniel; Girgis, Alexander A; Wang, Hejia Henry; Danilova, Ludmila; Heumann, Thatcher; Berg, Maureen; Wang, Yuxuan; Andaloori, Lalitya; Hernandez, Alexei; Longway, Gabriella; Barrett, Benjamin; Zhu, Zirui; Davis-Marcisak, Emily; Thoburn, Christopher; Leatherman, James; Mitchell, Sarah; Lee, Jae W; Shu, Daniel H; Konig, Maximillian F; Mog, Brian J; Montagne, Janelle; Coyne, Erin M; Bever, Katherine; Baretti, Marina; Yarchoan, Mark; Anders, Robert A; Kagohara, Luciane T; Laheru, Daniel; Thomas, Amy M; Durham, Jennifer; Nauroth, Julie M; Lu, Jiayun; Wang, Hao; Fertig, Elana J; Ho, Won Jin; Azad, Nilofer S; Jaffee, Elizabeth M; Zaidi, Neeha

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

突变型 KRAS 疫苗联合双重检查点阻断治疗切除的胰腺癌:一项 I 期试验。

Huff Amanda L, Haldar S Daniel, Gergis Alexander A, Wang Hejia Henry, Danilova Ludmila, Heumann Thatcher, Berg Maureen, Wang Yuxuan, Andaloori Lalitya, Hernandez Alexei, Longway Gabriella, Barrett Benjamin, Zhu Zirui, Davis-Marcisak Emily, Thoburn Christopher, Leatherman James, Mitchell Sarah, Lee Jae W, Shu Daniel H, Konig Maximillian F, Mog Brian J, Montagne Janelle, Coyne Erin M, Bever Katherine, Baretti Marina, Yarchoan Mark, Anders Robert A, Kagohara Luciane T, Laheru Daniel, Thomas Amy M, Durham Jennifer, Nauroth Julie M, Lu Jiayun, Wang Hao, Fertig Elana J, Ho Won Jin, Azad Nilofer S, Jaffee Elizabeth M, Zaidi Neeha

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma

首次注射免疫检查点抑制剂的时间会影响肝细胞癌的临床结果和免疫反应。

Li, Howard L; Charmsaz, Soren; Reisman, Benjamin J; Hayek, Franshisca; Brancati, Madelena; Leatherman, James M; Pazzi, Carlotta; Lee, Royce P; Zhao, Xiyu; Christenson, Eric; Arif, Waqar; Hernandez, Jeric; Ellis, Caroline; Gross, Nicole E; Thoburn, Chris; Chandler, G Scott; Mohindra, Rajat; Bansal, Sanjay; Tang, Laura; Guha, Aditi; Dang, Chi V; Zaidi, Neeha; Jaffee, Elizabeth M; Laheru, Daniel; Zabransky, Daniel J; Barretti, Marina; Ho, Won Jin; Yarchoan, Mark; Nakazawa, Mari

Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83

全球重新分析证实肝母细胞瘤中不存在 DNAJB1::PRKACA 融合基因。评论 Fleifil 等人发表的题为“DNAJB1-PKAc 激酶在儿童肝癌年轻患者中表达并增强致癌通路”的文章(Cancers 2025, 17, 83)。

Arif, Waqar; Simon, Sanford M; O'Neill, Allison F; Putra, Juan; López-Terrada, Dolores H; Yarchoan, Mark; Zucman-Rossi, Jessica; Hirsch, Theo Z

Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events

免疫相关不良事件患者多器官损伤的分子证据

Wang, Yuxuan; Li, Howard L; Bettegowda, Chetan; Kinzler, Kenneth W; Papadopoulos, Nickolas; Yarchoan, Mark; Vogelstein, Bert

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

治疗纤维板层型肝细胞癌的治疗性肽疫苗:一项 I 期试验

Baretti, Marina; Kirk, Allison M; Ladle, Brian H; Kamdar, Zeal; Bendinelli, Kayla J; Ho, Won Jin; Adhikari, Samir; Clark, Nicholas A; Sundararaman, Balaji; Wang, Hao; Kung, Heng-Chung; Hernandez, Jeric; Qi, Hanfei; Shin, Sarah M; Hernandez, Alexei; Nakazawa, Mari; Schattgen, Stefan A; Crawford, Jeremy Chase; Furth, Mark; Anders, Robert A; Thoburn, Chris; Zaidi, Neeha; Huff, Amanda L; Nauroth, Julie; Jaffee, Elizabeth; Pogorelyy, Mikhail V; Thomas, Paul G; Yarchoan, Mark

Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma

肿瘤部位影响胆管癌临床前模型中MEK抑制剂和免疫疗法联合治疗的疗效

Hammons, Jacklyn N; Warren, Emilie K; Wittling, Megen C; Bennett, Frances J; Rangel-Rivera, Guillermo O; Mack, Alexis F; Phillips, Maggie J; Robinson, Brian S; Krasinskas, Alyssa M; Horvat, Natalie K; Ruffin, Ayana T; Liu, Yuan; Cao, Yichun; Azad, Nilofer N S; Yarchoan, Mark M; Heumann, Thatcher; Keler, Tibor; Maithel, Shishir K; Paulos, Chrystal M; Lesinski, Gregory B

Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.

肿瘤来源的 CCL2 驱动 IDH1 突变型胆管癌的肿瘤生长和免疫抑制

Zabransky Daniel J, Kartalia Emma, Lee Jae W, Leatherman James M, Charmsaz Soren, Young Sara E, Chhabra Yash, Franch-Expósito SebastiÃ, Kang Martin, Maru Saumya, Rastkari Noushin, Davis Michael, Dalton William Brian, Oshima Kiyoko, Baretti Marina, Azad Nilofer S, Jaffee Elizabeth M, Yarchoan Mark

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

接受免疫检查点抑制剂治疗的实体瘤患者循环免疫反应的年龄相关性差异

Kao, Chester; Charmsaz, Soren; Tsai, Hua-Ling; Aziz, Khaled; Shu, Daniel H; Munjal, Kabeer; Griffin, Ervin; Leatherman, James M; Lipson, Evan J; Ged, Yasser; Hoffman-Censits, Jeannie; Li, Howard L; Hallab, Elsa; Brancati, Madelena; Nakazawa, Mari; Alden, Stephanie; Thoburn, Christopher; Gross, Nicole E; Hernandez, Alexei G; Coyne, Erin M; Kartalia, Emma; Baretti, Marina; Jaffee, Elizabeth M; Bansal, Sanjay; Tang, Laura; Chandler, G Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark; Zabransky, Daniel J

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

接受免疫治疗的实体瘤患者的免疫相关事件与 Th17 和 Th2 特征相关。

Kao, Chester J; Charmsaz, Soren; Alden, Stephanie L; Brancati, Madelena; Li, Howard L; Balaji, Aanika; Munjal, Kabeer; Howe, Kathryn; Mitchell, Sarah; Leatherman, James; Griffin, Ervin; Nakazawa, Mari; Tsai, Hua-Ling; Danilova, Ludmila; Thoburn, Chris; Gizzi, Jennifer; Gross, Nicole E; Hernandez, Alexei; Coyne, Erin M; Shin, Sarah M; Suresh Babu, Jayalaxmi; Apostol, George W; Durham, Jennifer; Christmas, Brian J; Konig, Maximilian F; Lipson, Evan J; Naidoo, Jarushka; Cappelli, Laura C; Pabani, Aliyah; Ged, Yasser; Baretti, Marina; Brahmer, Julie; Hoffman-Censits, Jean; Seiwert, Tanguy Y; Garonce-Hediger, Rachel; Guha, Aditi; Bansal, Sanjay; Tang, Laura; Jaffee, Elizabeth M; Chandler, G Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark